Literature DB >> 10914999

Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital.

T Nishikawa1, M Omura.   

Abstract

We studied 1,020 patients with hypertension visiting our outpatient clinic during a five-year period, from 1995 until 1999. Those subjects were screened by determining plasma renin activity (PRA) and plasma aldosterone concentration (PAC) after testing routine laboratory examinations in order to differentiate secondary hypertension from essential hypertension. All patients with low-reninemic hypertension were examined by furosemide plus the upright test. This led to an increase in diagnoses of primary aldosteronism (PA) (confirmed by captopril-loading test). Our studies demonstrated that the incidence of PA is 5.4%, and also that the plasma potassium level is not always beneficial for suspecting the presence of PA, because 28% of the patients with PA show only hypokalemia. We would like to emphasize that adrenal venous sampling plays a critical role in establishing the optimal management for patients with PA, because CT imaging is limited to detection of adrenal masses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10914999     DOI: 10.1016/s0753-3322(00)80019-0

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  13 in total

Review 1.  Primary aldosteronism: rare bird or common cause of secondary hypertension?

Authors:  M Stowasser
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 2.  Primary aldosteronism: a needle in a haystack or a yellow cab on Fifth Avenue?

Authors:  Gian Paolo Rossi
Journal:  Curr Hypertens Rep       Date:  2004-02       Impact factor: 5.369

3.  A subtype prediction score for primary aldosteronism.

Authors:  K Nanba; M Tsuiki; K Nakao; A Nanba; T Usui; T Tagami; Y Hirokawa; H Okuno; T Suzuki; T Shimbo; A Shimatsu; M Naruse
Journal:  J Hum Hypertens       Date:  2014-04-03       Impact factor: 3.012

Review 4.  A comprehensive review of the clinical aspects of primary aldosteronism.

Authors:  Gian Paolo Rossi
Journal:  Nat Rev Endocrinol       Date:  2011-05-24       Impact factor: 43.330

Review 5.  Diagnosis and treatment of primary aldosteronism.

Authors:  Gian Paolo D Rossi
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

Review 6.  Primary aldosteronism: from bench to bedside.

Authors:  Norlela Sukor
Journal:  Endocrine       Date:  2011-11-01       Impact factor: 3.633

Review 7.  Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.

Authors:  Laurence Amar; Pierre-François Plouin; Olivier Steichen
Journal:  Orphanet J Rare Dis       Date:  2010-05-19       Impact factor: 4.123

8.  Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients.

Authors:  Carrie C Lubitz; Konstantinos P Economopoulos; Stephen Sy; Colden Johanson; Heike E Kunzel; Martin Reincke; G Scott Gazelle; Milton C Weinstein; Thomas A Gaziano
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-11-10

Review 9.  Primary aldosteronism: A Japanese perspective.

Authors:  Fumitoshi Satoh; Ryo Morimoto; Yoshitsugu Iwakura; Yoshikiyo Ono; Masataka Kudo; Kei Takase; Sadayoshi Ito
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

10.  Is it Possible to Extirpate Cardiovascular Events in Primary Aldosteronism After Surgical Treatment.

Authors:  Tetsuo Nishikawa; Yoko Matsuzawa; Jun Saito; Masao Omura
Journal:  Jpn Clin Med       Date:  2010-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.